1. Home
  2. SNDX vs QCRH Comparison

SNDX vs QCRH Comparison

Compare SNDX & QCRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • QCRH
  • Stock Information
  • Founded
  • SNDX 2005
  • QCRH 1993
  • Country
  • SNDX United States
  • QCRH United States
  • Employees
  • SNDX N/A
  • QCRH N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • QCRH Major Banks
  • Sector
  • SNDX Health Care
  • QCRH Finance
  • Exchange
  • SNDX Nasdaq
  • QCRH Nasdaq
  • Market Cap
  • SNDX 1.4B
  • QCRH 1.4B
  • IPO Year
  • SNDX 2016
  • QCRH 1993
  • Fundamental
  • Price
  • SNDX $13.63
  • QCRH $86.64
  • Analyst Decision
  • SNDX Strong Buy
  • QCRH Buy
  • Analyst Count
  • SNDX 11
  • QCRH 3
  • Target Price
  • SNDX $37.64
  • QCRH $76.00
  • AVG Volume (30 Days)
  • SNDX 1.9M
  • QCRH 65.2K
  • Earning Date
  • SNDX 11-05-2024
  • QCRH 01-21-2025
  • Dividend Yield
  • SNDX N/A
  • QCRH 0.28%
  • EPS Growth
  • SNDX N/A
  • QCRH 6.88
  • EPS
  • SNDX N/A
  • QCRH 6.88
  • Revenue
  • SNDX $16,000,000.00
  • QCRH $341,805,000.00
  • Revenue This Year
  • SNDX N/A
  • QCRH N/A
  • Revenue Next Year
  • SNDX N/A
  • QCRH $10.78
  • P/E Ratio
  • SNDX N/A
  • QCRH $12.54
  • Revenue Growth
  • SNDX N/A
  • QCRH 5.07
  • 52 Week Low
  • SNDX $13.26
  • QCRH $53.22
  • 52 Week High
  • SNDX $25.34
  • QCRH $96.08
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 30.64
  • QCRH 41.23
  • Support Level
  • SNDX $13.36
  • QCRH $86.11
  • Resistance Level
  • SNDX $14.18
  • QCRH $91.49
  • Average True Range (ATR)
  • SNDX 0.81
  • QCRH 1.84
  • MACD
  • SNDX -0.18
  • QCRH -0.94
  • Stochastic Oscillator
  • SNDX 11.32
  • QCRH 0.40

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About QCRH QCR Holdings Inc.

QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely QCBT, CRBT, CSB, and GB. It generates revenue in the form of interest.

Share on Social Networks: